Survival advantage and clinicopathological significance of microRNA-22 in cancers: a meta-analysis
Qingming Xiang,1,* Zhenxian Xiang,2,* Rongzhang Dou,2 Bin Xiong2 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Hubei Key Laboratory of Tumor Biological Behaviors & Hubei Cancer Clinical Study Center, Wuhan 430071, People’s Republic of China;...
Main Authors: | Xiang Q, Xiang Z, Dou R, Xiong B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-10-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/survival-advantage-and-clinicopathological-significance-of-microrna-22-peer-reviewed-article-CMAR |
Similar Items
-
Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis
by: Min Sun, et al.
Published: (2019-03-01) -
Hsa-miR-21 and Hsa-miR-29 in Tissue as Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer
by: Dahu Wang, et al.
Published: (2015-10-01) -
High expression of USP22 predicts poor prognosis and advanced clinicopathological features in solid tumors: a meta-analysis
by: Yang XH, et al.
Published: (2018-05-01) -
Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes
by: E. Ntoumou, et al.
Published: (2017-12-01) -
Clinicopathological and prognostic significance of nestin expression in patients with breast cancer: a systematic review and meta-analysis
by: Xinyi Zhang, et al.
Published: (2020-05-01)